Finance

Lists
002737:SHE
Sunflower Pharmaceutical Group Co Ltd
CNÂ¥11.17
+0.09%
(+0.010) 1D
Oct 16, 3:04:33 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002737...
Open
CNÂ¥11.25
High
CNÂ¥11.43
Low
CNÂ¥11.10
Mkt. cap
6.62B
Avg. vol.
4.66M
Volume
4.94M
Dividend
1.79%
Quarterly dividend
CNÂ¥0.05
Ex-dividend date
Jul 17, 2026
52-wk high
CNÂ¥15.66
52-wk low
CNÂ¥11.04
EPS
-CNÂ¥0.44
Shares outstanding
584.00M
No. of employees
5K
Open
CNÂ¥11.25
High
CNÂ¥11.43
Low
CNÂ¥11.10
Mkt. cap
6.62B
Avg. vol.
4.66M
Volume
4.94M
Dividend
1.79%
Quarterly dividend
CNÂ¥0.05
Ex-dividend date
Jul 17, 2026
52-wk high
CNÂ¥15.66
52-wk low
CNÂ¥11.04
EPS
-CNÂ¥0.44
Shares outstanding
584.00M
No. of employees
5K
News stories
From web sources and news partners
About Sunflower Pharmaceutical Group Co Ltd
CEO-
Employees5.02K
FoundedSep 7, 2005
Headquarters-
SectorPharmaceutical industry
Websitekuihuayaoye.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
373.84M
633.97M
843.92M
654.04M
Cost of goods sold
244.90M
421.76M
368.49M
323.76M
Cost of revenue
244.90M
421.76M
368.49M
323.76M
Research and development expenses
20.93M
45.00M
23.41M
24.69M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
234.98M
392.99M
286.51M
344.76M
Operating expense
216.68M
483.64M
317.81M
382.50M
Total operating expenses
461.58M
905.40M
686.30M
706.26M
Operating income
-87.74M
-271.42M
157.62M
-52.22M
Other non operating income
3.04M
-3.63M
1.06M
-1.44M
EBT including unusual items
-118.70M
-264.92M
141.49M
-41.64M
EBT excluding unusual items
-74.54M
-263.57M
168.26M
-46.91M
Income tax expense
8.79M
-13.76M
25.70M
-11.33M
Effective tax rate
-7.40%
5.19%
18.16%
27.20%
Other operating expenses
-41.88M
58.64M
5.59M
16.01M
Net income
-114.85M
-224.29M
110.29M
-30.82M
Net profit margin
-30.72%
-35.38%
13.07%
-4.71%
Earnings per share
-
-
-
-
Interest and investment income
10.59M
14.26M
10.47M
7.87M
Interest expense
-443.58K
-2.47M
-882.04K
-1.03M
Net interest expenses
10.14M
11.79M
9.59M
6.84M
Depreciation and amortization charges
-
-
-
-
EBITDA
-44.53M
-230.08M
198.97M
-15.31M
Gain or loss from assets sale
-653.72K
654.46K
-
140.13K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps